Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.05 (4.76%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.10
Low: 1.10
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

26 Aug 2020 09:04

RNS Number : 2063X
Nplus1 Singer Capital Markets Ltd
26 August 2020
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MICROSAIC SYSTEMS PLC

 

(c) Name of the party to the offer with which exempt principal trader is connected:

MICROSAIC SYSTEMS PLC

(d) Date dealing undertaken:

25 August 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.25P

 

 

Sale

 

550,000

 

0.5149p

 

0.5149p

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

26 August 2020

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGZGZRRVFGGZG
Date   Source Headline
10th Aug 20204:33 pmBUSForm 8.3 - Microsaic Systems
10th Aug 202010:08 amRNSForm 8.5 (EPT/RI)
7th Aug 20204:59 pmRNSForm 8.3 - Microsaic Systems PLC
7th Aug 20209:14 amRNSForm 8.5 (EPT/RI)
6th Aug 202012:07 pmRNSForm 8.5 (EPT/RI)
5th Aug 202010:04 amRNSForm 8.5 (EPT/RI)
4th Aug 20202:31 pmRNSForm 8.3 - Microsaic Systems PLC
4th Aug 202011:39 amRNSForm 8.5 (EPT/RI)
3rd Aug 20201:54 pmRNSForm 8.3 - Microsaic Systems plc
3rd Aug 202011:24 amRNSForm 8.5 (EPT/RI)
31st Jul 20204:06 pmRNSForm 8 (OPD) Microsaic Systems plc
31st Jul 20201:43 pmRNSForm 8.3 - Microsaic Systems plc
31st Jul 20209:37 amRNSForm 8.5 (EPT/RI)
31st Jul 20209:11 amRNSForm 8.3 - Microsaic Systems plc
30th Jul 20204:03 pmRNSParkwalk Advisors: Form 8.3- Microsaic Systems plc
30th Jul 202011:47 amRNSForm 8.5 (EPT/RI)
29th Jul 20205:48 pmGNWForm 8.3 - Microsaic Systems plc
29th Jul 202012:00 pmRNSForm 8.3 - Microsaic Systems plc
29th Jul 20207:00 amRNSStrategic Review and Formal Sale Process
25th Jun 20203:16 pmRNSResult of AGM
1st Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20207:00 amRNSCOVID-19 Update
9th Mar 20207:00 amRNSFinal Results
3rd Mar 20207:00 amRNSAppointment of WH Ireland as Joint Broker
26th Feb 20207:00 amRNSGlobal collaboration agreement with Axcend Corp
16th Jan 20207:00 amRNSPre-close Trading Update
16th Dec 20197:00 amRNSMicrosaic collaborates with the CPI
6th Dec 20194:35 pmRNSPrice Monitoring Extension
5th Dec 20199:05 amRNSSecond Price Monitoring Extn
5th Dec 20199:00 amRNSPrice Monitoring Extension
5th Dec 20197:00 amRNSExclusive Japan Distribution Agreement
13th Nov 20194:41 pmRNSSecond Price Monitoring Extn
13th Nov 20194:35 pmRNSPrice Monitoring Extension
26th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSNotice of Results
12th Jun 20191:38 pmRNSAward of options
7th Jun 20197:00 amRNSDistribution Agreement with CM Corporation Ltd.
3rd Jun 20197:00 amRNSCost and time savings in manufacture of biologics
16th May 20192:06 pmRNSBoard Change
14th May 201912:00 pmRNSResult of AGM
14th May 201911:05 amRNSSecond Price Monitoring Extn
14th May 201911:00 amRNSPrice Monitoring Extension
14th May 20197:00 amRNSAGM Statement
2nd May 20197:00 amRNSDeepened collaboration with Chinese partner
12th Apr 20197:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20197:00 amRNSOEM Agreement
11th Mar 20197:00 amRNSFinal Results
5th Mar 20197:00 amRNSInvestor Event
5th Mar 20197:00 amRNSMSYS jointly publishes bioprocessing data with MIT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.